Elbion Overview
Update this profile
Elbion General Information
Description
Provider of pharmaceutical research and development services. The company operates as a specialty pharmaceutical company focused on the development and commercialization of therapeutics for neurological diseases and immunological disorders.
Want to dig into this profile?
We’ll help you find what you need
Learn more
Elbion Patents
99
Total Documents
Applications and Grants
000
Total Patents
Families
000
Granted
000
Pending
000
Expiring
in next 12 mo
Elbion Recent Patent Activity
Publication ID
Patent Title
Status
First Filing Date
Technology (CPC)
Citations
CA-2706986-A1
Aryl and heteroaryl fused imidazo (1,5-a) pyrazines as inhibitors of phosphodiesterase 10
Abandoned
30-Nov-2007
0000000000
AU-2008329072-A1
Aryl and heteroaryl fused imidazo (1,5-a) pyrazines as inhibitors of phosphodiesterase 10
Abandoned
30-Nov-2007
0000000000
US-20090143391-A1
Aryl and heteroaryl fused imidazo [1,5-a] pyrazines as inhibitors of phosphodiesterase 10
Abandoned
30-Nov-2007
0000000000
0
US-20090143392-A1
Methods of treating obesity and metabolic disorders
Abandoned
30-Nov-2007
00000000000
0
EP-2227472-A1
Aryl and heteroaryl fused imidazo (1,5-a) pyrazines as inhibitors of phosphodiesterase 10
Withdrawn
30-Nov-2007
C07D487/04
To view Elbion’s complete patent history, request access »